MUC16 and ovarian carcinoma: We observed a pro-tumorigenic role of MSLN, in MUC16 deficient (OVCAR8) and proficient (OVCAR3, BG1, and OVCAR4) ovarian cancer cell lines33 which suggests that MSLN can act in a MUC16-independent manner.